FEMA Funding - What You Should Know
You may have received an email regarding a FEMA program that would provide funding specifically for the drug, Lucemyra, free to jails. Information like this may pique your attention and cause you to consider switching medications with the hopes of lowering your out-of-pocket cost. Our goal is to arm you with information so that you are informed before you make a decision.
Don’t fall for the sales pitch
Lucemyra is used specifically to treat withdrawal symptoms of opioid use disorder. However, Lucemyra has a similar action as Clonidine, which is effective in treating withdrawal symptoms and generally stocked at jails. It is important to understand that the same funding being advertised for Lucemyra is available for use in purchasing any medication or program being used to treat opioid use disorder. Lucemyra is also much more expensive than Clonidine – potentially putting a much larger dent in funding that may be available to your facility. Don’t fall for the sales pitch. Discuss any potential switch with your medical practitioner(s) first.
Know what experts are recommending
The NCCHC and American Society of Addiction Medicine (ASAM) are pushing towards medication assisted treatment (MAT) programs. Lucemyra does not fall into the category of medications used for MAT, as it does not treat opioid use disorder – it only helps manage the symptoms. Know what experts are recommending as you move toward considering a MAT program in your facility. Consult with your practitioner or nursing leader if you are interested in learning more about MAT programs.
If you would like additional information, please email training@sparktraining.us.
All materials have been prepared for general information purposes only. The information presented should be treated as guidelines, not rules. The information presented is not intended to establish a standard of medical care and is not a substitute for common sense. The information presented is not legal advice, is not to be acted on as such, may not be current, and is subject to change without notice. Each situation should be addressed on a case-by-case basis. WHEN IN DOUBT, SEND THEM OUT. ®